Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
320905 | European Neuropsychopharmacology | 2008 | 11 Pages |
Previously, we have reported that the orexigenic peptide ghrelin activates the cholinergic–dopaminergic reward link, involving nicotinic acetylcholine receptors (nAChR). The α3-α7 and β2-β4 subunits of the nAChR can be combined into pentameric nAChRs, with different functional roles. The present experiments show that the locomotor stimulatory effects of ghrelin, either into laterodorsal tegmental area (LDTg) or ventral tegmental area (VTA), are mediated via ventral tegmental nAChR, but neither the α4β2⁎ (using dihydro-β-erythroidine) nor the α7⁎ (using methyllycaconitine) subtypes appears to be involved. On the other hand, the α3β2⁎, β3⁎ and/or α6⁎ (using α-conotoxin MII) subtypes in the VTA mediate the stimulatory and DA-enhancing effects of ghrelin, a pattern that ghrelin shares with ethanol (n = 5–8). Radioligand-binding experiments shown that ghrelin does not interfere directly with nAChRs (n = 26). We therefore suggest that the α3β2⁎, β3⁎ and/or α6⁎ subtypes might be pharmacological targets for treatment of addictive behaviours including compulsive overeating and alcoholism.